JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB109530

Anti-Proteasome 20S C2/HC2 antibody [EPR5452]

Be the first to review this product! Submit a review

|

(6 Publications)

Rabbit Recombinant Monoclonal PSA1 antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 6 publications.

View Alternative Names

HC2, NU, PROS30, PSC2, PSMA1, Proteasome subunit alpha type-1, 30 kDa prosomal protein, Macropain subunit C2, Multicatalytic endopeptidase complex subunit C2, Proteasome component C2, Proteasome nu chain, Proteasome subunit alpha-6, PROS-30, alpha-6

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Proteasome 20S C2/HC2 antibody [EPR5452] (AB109530)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Proteasome 20S C2/HC2 antibody [EPR5452] (AB109530)

ab109530 at 1/100 dilution staining Proteasome 20S C2/HC2 in paraffin embedded Human medullary carcinoma tissue by Immunohistochemistry.

Perform heat mediated antigen retrieval via the pressure cooker method before commencing with IHC staining protocol.

Western blot - Anti-Proteasome 20S C2/HC2 antibody [EPR5452] (AB109530)
  • WB

Unknown

Western blot - Anti-Proteasome 20S C2/HC2 antibody [EPR5452] (AB109530)

All lanes:

Western blot - Anti-Proteasome 20S C2/HC2 antibody [EPR5452] (ab109530) at 1/1000 dilution

Lane 1:

Jurkat cell lysate at 10 µg

Lane 2:

HeLa cell lysate at 10 µg

Lane 3:

HepG2 cell lysate at 10 µg

Lane 4:

PC3 cell lysates at 10 µg

Predicted band size: 30 kDa

false

  • Carrier free

    Anti-Proteasome 20S C2/HC2 antibody [EPR5452] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR5452

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

style
left-column

Alternative Products

Primary Antibodies

AB140499

Anti-Proteasome 20S C2/HC2 antibody

Immunoprecipitation - Anti-Proteasome 20S C2/HC2 antibody (AB140499)

  • 0
  • 0
Primary Antibodies

AB109500

Anti-Proteasome 20S C2/HC2 antibody [EPR5451]

RabMAb|Recombinant

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Proteasome 20S C2/HC2 antibody [EPR5451] (AB109500)

  • 0
  • 0
Primary Antibodies

AB3325

Anti-Proteasome 20S C2/HC2 antibody

Immunocytochemistry/ Immunofluorescence - Anti-Proteasome 20S C2/HC2 antibody (AB3325)

  • 5
  • 2

Complementary Products

Assay Kits

AB107921

Proteasome Activity Assay Kit

Functional Studies - Proteasome Activity Assay Kit (AB107921)

  • 4
  • 2
Primary Antibodies

AB180606

Anti-Proteasome 20S LMP7 antibody [EPR14482(B)]

20ul selling size|BOND RX™ Validated|RabMAb|Recombinant|KO Validated

Flow Cytometry (Intracellular) - Anti-Proteasome 20S LMP7 antibody [EPR14482(B)] (AB180606)

  • 5
  • 1
Primary Antibodies

AB242061

Anti-Proteasome 20S LMP2 antibody [EPR22042]

RabMAb|Recombinant|KO Validated|20ul selling size

Flow Cytometry (Intracellular) - Anti-Proteasome 20S LMP2 antibody [EPR22042] (AB242061)

  • 0
  • 0
Primary Antibodies

AB22673

Anti-Proteasome 20S alpha + beta antibody

Immunocytochemistry/ Immunofluorescence - Anti-Proteasome 20S alpha + beta antibody (AB22673)

  • 5
  • 7
Primary Antibodies

AB317398

Anti-Proteasome subunit alpha type 6 antibody [S01-4I2]

Recombinant

Immunocytochemistry/ Immunofluorescence - Anti-Proteasome subunit alpha type 6 Antibody [S01-4I2] (AB317398)

  • 0
  • 0
style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/250", "IHCP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Rat": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }
style
left-column

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

style
left-column

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Conditional Ambient
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Proteasome 20S C2/HC2 also known as the proteasome subunit beta type-1 represents an important component of the proteasome complex. This protein performs proteolytic functions degrading ubiquitinated proteins into peptides. The proteasome 20S C2/HC2 has a molecular mass of approximately 23 kDa and is expressed in various tissues throughout the body including muscle and nerve tissues. It forms part of the 20S core particle of the proteasome complex and contributes to protein homeostasis.
Biological function summary

Proteasome 20S C2/HC2 plays a significant role in maintaining protein quality by participating in proteolytic degradation. It forms part of the larger 26S proteasome complex which assembles with regulatory particles for substrate recognition. This protein is essential for the breakdown and removal of oxidized or misfolded proteins thereby preventing the accumulation of potentially toxic aggregates within the cell. It ensures cellular regulation by processing proteins that control various aspects of cell cycle signaling and differentiation.

Pathways

The activity of the Proteasome 20S C2/HC2 integrates directly into the ubiquitin-proteasome pathway. This pathway regulates protein turnover and plays a vital role in cellular processes such as the cell cycle and apoptosis. The association with proteins such as ubiquitin and E3 ligases is critical for the marking of substrate proteins for degradation. This protein is also linked to the NF-kB signaling pathway interacting with proteins that modulate immune and inflammatory responses demonstrating its influence on broader regulatory networks.

Proteasome 20S C2/HC2 disruption has been identified in various pathological conditions. Abnormal function or expression levels relate to neurodegenerative disorders like Parkinson’s disease where inefficient protein degradation leads to protein aggregation. This protein also connects to tumor progression in cancers where alterations in the ubiquitin-proteasome system affect cell cycle regulation and apoptosis. The protein's interaction with tumor suppressors and oncogenes highlights its significance in cellular growth abnormalities.
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

Component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins. The 26S proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. Associated with the PA200 or PA28, the 20S proteasome mediates ubiquitin-independent protein degradation. This type of proteolysis is required in several pathways including spermatogenesis (20S-PA200 complex) or generation of a subset of MHC class I-presented antigenic peptides (20S-PA28 complex).
See full target information PSMA1
style
left-column

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

Cell death & disease 13:989 PubMed36424389

2022

PSMA1 mediates tumor progression and poor prognosis of gastric carcinoma by deubiquitinating and stabilizing TAZ.

Applications

Unspecified application

Species

Unspecified reactive species

Qinyu Yang,Ying Lu,Jianfang Shangguan,Xu Shu

Cell reports 41:111536 PubMed36288698

2022

Yeast Smy2 and its human homologs GIGYF1 and -2 regulate Cdc48/VCP function during transcription stress.

Applications

Unspecified application

Species

Unspecified reactive species

Michelle Harreman Lehner,Jane Walker,Kotryna Temcinaite,Anna Herlihy,Michael Taschner,Adam C Berger,Anita H Corbett,A Barbara Dirac Svejstrup,Jesper Q Svejstrup

JCI insight 7: PubMed35393946

2022

Blockade of the CXCR3/CXCL10 axis ameliorates inflammation caused by immunoproteasome dysfunction.

Applications

Unspecified application

Species

Unspecified reactive species

Yuki Sasaki,Hideki Arimochi,Kunihiro Otsuka,Hiroyuki Kondo,Shin-Ichi Tsukumo,Koji Yasutomo

Frontiers in aging neuroscience 10:186 PubMed29997495

2018

Preventing P-gp Ubiquitination Lowers Aβ Brain Levels in an Alzheimer's Disease Mouse Model.

Applications

Unspecified application

Species

Unspecified reactive species

Anika M S Hartz,Yu Zhong,Andrew N Shen,Erin L Abner,Björn Bauer

American journal of physiology. Endocrinology and metabolism 311:E436-48 PubMed27382037

2016

Hypermetabolism and hypercatabolism of skeletal muscle accompany mitochondrial stress following severe burn trauma.

Applications

Unspecified application

Species

Unspecified reactive species

John O Ogunbileje,Craig Porter,David N Herndon,Tony Chao,Doaa R Abdelrahman,Anastasia Papadimitriou,Maria Chondronikola,Teresa A Zimmers,Paul T Reidy,Blake B Rasmussen,Labros S Sidossis

Nature 513:440-3 PubMed25043031

2014

Coordinated regulation of protein synthesis and degradation by mTORC1.

Applications

Unspecified application

Species

Unspecified reactive species

Yinan Zhang,Justin Nicholatos,John R Dreier,Stéphane J H Ricoult,Scott B Widenmaier,Gökhan S Hotamisligil,David J Kwiatkowski,Brendan D Manning
View all publications
style
left-column
style
left-column
style
right-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com